Menopause resident survival guide: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(16 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
 
{| class="infobox" style="margin: 0 0 0 0; border: 0; float: right; width: 100px; background: #A8A8A8; position: fixed; top: 250px; right: 21px; border-radius: 0 0 10px 10px;" cellpadding="0" cellspacing="0" ;
|-
! style="padding: 0 5px; font-size: 85%; background: #A8A8A8" align="center" |{{fontcolor|#2B3B44|Menopause Resident Survival Guide Microchapters}}
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Menopause resident survival guide#Overview|Overview]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Menopause resident survival guide#Causes|Causes]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Menopause resident survival guide#Diagnosis|Diagnosis]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Menopause resident survival guide#Treatment|Treatment]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Menopause resident survival guide#Do's|Do's]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Menopause resident survival guide#Don'ts|Don'ts]]
|}
{{WikiDoc CMG}}; {{AE}} {{Ayeesha}}
{{WikiDoc CMG}}; {{AE}} {{Ayeesha}}


{{SK}}
{{SK}} Perimenopause approach, Climacteric workup, Approach to menopause, Menopause workup, Menopause management
==Overview==
==Overview==
This section provides a short and straight to the point overview of the disease or symptom. The first sentence of the overview must contain the name of the disease.
[[Menopause]] is a clinical state indicating the permanent cessation of [[ovarian]] function. [[Perimenopause]] refers to the period of transitioning before [[menopause]] characterised by irregular [[menstrual]] cycles. The diagnosis of [[menopause]] is made retrospectively based on the absence of [[menstrual]] cycles for 12 months. The average age of [[menopause]] is 51 years. Women can have symptoms of [[hot flashes]], night sweats, sleep disturbance, mood changes, decreased [[libido]], [[vaginal]] dryness, [[dyspareunia]], etc. Women with intolerable symptoms can be treated with [[hormonal]] and [[non hormonal]] therapy. Conditions where [[menopause]] can occur early are [[primary ovarian insufficiency]], bilateral [[oophorectomy]], [[chemotherapy]] and [[radiation]] induced.


==Causes==
==Causes==
===Life Threatening Causes===
===Common Causes===
Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated.
Commn causes of menopause include: <ref name="pmid26316241">{{cite journal| author=Rodriguez M, Shoupe D| title=Surgical Menopause. | journal=Endocrinol Metab Clin North Am | year= 2015 | volume= 44 | issue= 3 | pages= 531-42 | pmid=26316241 | doi=10.1016/j.ecl.2015.05.003 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26316241  }} </ref> <ref name="pmid31416275">{{cite journal| author=Secoșan C, Balint O, Pirtea L, Grigoraș D, Bălulescu L, Ilina R| title=Surgically Induced Menopause-A Practical Review of Literature. | journal=Medicina (Kaunas) | year= 2019 | volume= 55 | issue= 8 | pages=  | pmid=31416275 | doi=10.3390/medicina55080482 | pmc=6722518 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31416275  }} </ref> <ref name="pmid29225794">{{cite journal| author=Torrealday S, Kodaman P, Pal L| title=Premature Ovarian Insufficiency - an update on recent advances in understanding and management. | journal=F1000Res | year= 2017 | volume= 6 | issue=  | pages= 2069 | pmid=29225794 | doi=10.12688/f1000research.11948.1 | pmc=5710309 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29225794  }} </ref> <ref name="pmid26485568">{{cite journal| author=Liem GS, Mo FK, Pang E, Suen JJ, Tang NL, Lee KM | display-authors=etal| title=Chemotherapy-Related Amenorrhea and Menopause in Young Chinese Breast Cancer Patients: Analysis on Incidence, Risk Factors and Serum Hormone Profiles. | journal=PLoS One | year= 2015 | volume= 10 | issue= 10 | pages= e0140842 | pmid=26485568 | doi=10.1371/journal.pone.0140842 | pmc=4613138 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26485568  }} </ref>
* [[Life threatening cause 1]]
* [[Life threatening cause 2]]
* [[Life threatening cause 3]]


===Common Causes===
*Natural [[menopause]]
* Natural [[menopause]]
*[[Premature ovarian failure]] or Early [[menopause]]
* [[Premature ovarian failure]] or Early [[menopause]]
*Surgical [[menopause]]
* Surgical [[menopause]]
*[[Chemotherapy]] and [[radiation]] induced [[menopause]]
* [[Chemotherapy]] and [[radiation]] induced [[menopause]]
<ref name="pmid26316241">{{cite journal| author=Rodriguez M, Shoupe D| title=Surgical Menopause. | journal=Endocrinol Metab Clin North Am | year= 2015 | volume= 44 | issue= 3 | pages= 531-42 | pmid=26316241 | doi=10.1016/j.ecl.2015.05.003 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26316241  }} </ref> <ref name="pmid31416275">{{cite journal| author=Secoșan C, Balint O, Pirtea L, Grigoraș D, Bălulescu L, Ilina R| title=Surgically Induced Menopause-A Practical Review of Literature. | journal=Medicina (Kaunas) | year= 2019 | volume= 55 | issue= 8 | pages=  | pmid=31416275 | doi=10.3390/medicina55080482 | pmc=6722518 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31416275  }} </ref> <ref name="pmid29225794">{{cite journal| author=Torrealday S, Kodaman P, Pal L| title=Premature Ovarian Insufficiency - an update on recent advances in understanding and management. | journal=F1000Res | year= 2017 | volume= 6 | issue=  | pages= 2069 | pmid=29225794 | doi=10.12688/f1000research.11948.1 | pmc=5710309 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29225794  }} </ref> <ref name="pmid26485568">{{cite journal| author=Liem GS, Mo FK, Pang E, Suen JJ, Tang NL, Lee KM | display-authors=etal| title=Chemotherapy-Related Amenorrhea and Menopause in Young Chinese Breast Cancer Patients: Analysis on Incidence, Risk Factors and Serum Hormone Profiles. | journal=PLoS One | year= 2015 | volume= 10 | issue= 10 | pages= e0140842 | pmid=26485568 | doi=10.1371/journal.pone.0140842 | pmc=4613138 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26485568  }} </ref>


==Diagnosis==
==Diagnosis==
Shown below is an algorithm summarizing the diagnosis of [[menopause]]. <ref name="StuenkelDavis2015">{{cite journal|last1=Stuenkel|first1=Cynthia A.|last2=Davis|first2=Susan R.|last3=Gompel|first3=Anne|last4=Lumsden|first4=Mary Ann|last5=Murad|first5=M. Hassan|last6=Pinkerton|first6=JoAnn V.|last7=Santen|first7=Richard J.|title=Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline|journal=The Journal of Clinical Endocrinology & Metabolism|volume=100|issue=11|year=2015|pages=3975–4011|issn=0021-972X|doi=10.1210/jc.2015-2236}}</ref>
Shown below is an algorithm summarizing the diagnosis of [[menopause]]. <ref name="StuenkelDavis2015">{{cite journal|last1=Stuenkel|first1=Cynthia A.|last2=Davis|first2=Susan R.|last3=Gompel|first3=Anne|last4=Lumsden|first4=Mary Ann|last5=Murad|first5=M. Hassan|last6=Pinkerton|first6=JoAnn V.|last7=Santen|first7=Richard J.|title=Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline|journal=The Journal of Clinical Endocrinology & Metabolism|volume=100|issue=11|year=2015|pages=3975–4011|issn=0021-972X|doi=10.1210/jc.2015-2236}}</ref><ref>https://www.nice.org.uk/guidance/ng23/chapter/Recommendations</ref><ref>https://www.menopause.org.au/hp/gp-hp-resources/300-diagnosing-menopause</ref>
<ref>https://www.nice.org.uk/guidance/ng23/chapter/Recommendations</ref> <ref>https://www.menopause.org.au/hp/gp-hp-resources/300-diagnosing-menopause</ref>


{{familytree/start |summary= Menopause diagnosis Algorithm.}}
{{familytree/start |summary= Menopause diagnosis Algorithm.}}
Line 42: Line 51:


==Treatment==
==Treatment==
Shown below is an algorithm summarizing the treatment of [[menopause]]. <ref>{{cite web |url=https://www.aafp.org/afp/2014/0901/p338.html |title=ACOG Releases Clinical Guidelines on Management of Menopausal Symptoms - Practice Guidelines - American Family Physician |format= |work= |accessdate=}}</ref> <ref>{{cite web |url=https://www.nichd.nih.gov/health/topics/menopause/conditioninfo/treatments |title=What are the treatments for other symptoms of menopause? &#124; NICHD - Eunice Kennedy Shriver National Institute of Child Health and Human Development |format= |work= |accessdate=}}</ref>
Shown below is an algorithm summarizing the treatment of [[menopause]]. <ref name="StuenkelDavis2015">{{cite journal|last1=Stuenkel|first1=Cynthia A.|last2=Davis|first2=Susan R.|last3=Gompel|first3=Anne|last4=Lumsden|first4=Mary Ann|last5=Murad|first5=M. Hassan|last6=Pinkerton|first6=JoAnn V.|last7=Santen|first7=Richard J.|title=Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline|journal=The Journal of Clinical Endocrinology & Metabolism|volume=100|issue=11|year=2015|pages=3975–4011|issn=0021-972X|doi=10.1210/jc.2015-2236}}</ref>
<ref>{{cite web |url=https://www.aafp.org/afp/2014/0901/p338.html |title=ACOG Releases Clinical Guidelines on Management of Menopausal Symptoms - Practice Guidelines - American Family Physician |format= |work= |accessdate=}}</ref> <ref>{{cite web |url=https://www.nichd.nih.gov/health/topics/menopause/conditioninfo/treatments |title=What are the treatments for other symptoms of menopause? &#124; NICHD - Eunice Kennedy Shriver National Institute of Child Health and Human Development |format= |work= |accessdate=}}</ref>
{{familytree/start}}
{{familytree/start}}
{{familytree | | | | | | | | | | | | | | B01 | | | | | | | | | | |B01=[[Menopausal]] symptoms}}
{{familytree | | | | | | | | | | | | | | B01 | | | | | | | | | | |B01=[[Menopausal]] symptoms}}
{{familytree | | |,|-|-|-|-|-|-|-|-|-|-|-|+|-|-|-|-|-|-|-|-|-|-|.| | }}
{{familytree | | |,|-|-|-|-|-|-|-|-|-|-|-|+|-|-|-|-|-|-|-|-|-|-|.| | }}
{{familytree | | C01 | | | | | | | | | | C02 | | | | | | | | | C03 |C01=[[Genitourinary]]<br>syndrome of [[menopause]] <br> (vaginal dryness, itching,<br> dyspareunia, urinary incontinence)|C02= [[Vasomotor]] symptoms <br> (hot flashes, night sweats)|C03= Sleep problems}}
{{familytree | | C01 | | | | | | | | | | C02 | | | | | | | | | C03 |C01=[[Genitourinary]]<br>syndrome of [[menopause]] <br> ([[vaginal]] dryness, [[Vaginal itching|itching]],<br> [[dyspareunia]], [[urinary incontinence]])|C02= [[Vasomotor]] symptoms <br> (hot flashes, night sweats)|C03= Sleep problems}}
{{familytree | | |!| | | | | | | | | | | |!| | | | | | | | | | |!| |}}
{{familytree | | |!| | | | | | | | | | | |!| | | | | | | | | | |!| |}}
{{familytree | | D01 | | | | | | | | | | D02 | | | | | | | | | D03 |D01= Water based lubricants <br> Ospemifene <br> Vaginal oestrogen|D02= Based on patient preference |D03= Regular exercise, <br> Sleep hygiene, <br> Avoid alcohol and caffeine}}
{{familytree | | D01 | | | | | | | | | | D02 | | | | | | | | | D03 |D01= Water based lubricants <br> Ospemifene <br> Vaginal oestrogen|D02= Based on patient preference |D03= Regular exercise <br> Sleep hygiene <br> Avoid alcohol and caffeine}}
{{familytree | | | | | | | | | |,|-|-|-|-|^|-|-|-|-|.| | | | | | | | | |D05=D05}}
{{familytree | | | | | | | | | |,|-|-|-|-|^|-|-|-|-|.| | | | | | | | | |D05=D05}}
{{familytree | | | | | | | | | E01 | | | | | | | | E02 | | | | | | | | |E01=Life style<br> modification |E02=Medical therapy|}}
{{familytree | | | | | | | | | E01 | | | | | | | | E02 | | | | | | | | |E01=Life style<br> modification |E02=Medical therapy|}}
Line 56: Line 66:
{{familytree | | | | | | | | | | | | | | | G01 | | | | | | G02 | | | | |G01= Post [[hysterectomy]] status| G02= When [[hormonal]] use<br> is contraindicated <br> (History of [[breast cancer]],<br> [[Venous thromboembolism]],<br> Undiagnosed [[vaginal]] bleeding, etc.}}
{{familytree | | | | | | | | | | | | | | | G01 | | | | | | G02 | | | | |G01= Post [[hysterectomy]] status| G02= When [[hormonal]] use<br> is contraindicated <br> (History of [[breast cancer]],<br> [[Venous thromboembolism]],<br> Undiagnosed [[vaginal]] bleeding, etc.}}
{{familytree | | | | | | | | | | | | |,|-|-|^|-|-|.| | | | |!| | | |}}
{{familytree | | | | | | | | | | | | |,|-|-|^|-|-|.| | | | |!| | | |}}
{{familytree | | | | | | | | | | | | H01 | | | | H02 | | | H03 | | | | |H01= [[Hysterectomised]]| H02= [[Uterus]] in-situ |H03= [[Paroxetine]]([[SSRI]]) <br>[[Clonidine]] <br>[[Gabapentin]] <br>Clinical [[hypnosis]] }}
{{familytree | | | | | | | | | | | | H01 | | | | H02 | | | H03 | | | | |H01= [[Hysterectomised]]| H02= [[Uterus]] in-situ |H03= [[Paroxetine]]([[SSRI]]) <br>[[Clonidine]] <br>[[Gabapentin]]}}
{{familytree | | | | | | | | | | | | |!| | | | | |!| | | | | | | | |}}
{{familytree | | | | | | | | | | | | |!| | | | | |!| | | | | | | | |}}
{{familytree | | | | | | | | | | | | I01 | | | | I02 | | | | | | | | |I01= [[Oestrogen]] alone | I02= [[Oestrogen]]+[[Progesterone]] }}
{{familytree | | | | | | | | | | | | I01 | | | | I02 | | | | | | | | |I01= [[Oestrogen]] alone | I02= [[Oestrogen]]+[[Progesterone]] }}
Line 62: Line 72:


==Do's==
==Do's==
* The content in this section is in bullet points.
 
*In women with [[moderate]] risk of [[cardiovascular disease]] requiring treatment for [[vasomotor]] symptoms of [[menopause]], use [[transdermal]] [[estradiol]] alone or in combination with micronised [[progesterone]] in women with [[uterus]] instead of oral oestrogen preparations. <ref name="StuenkelDavis2015">{{cite journal|last1=Stuenkel|first1=Cynthia A.|last2=Davis|first2=Susan R.|last3=Gompel|first3=Anne|last4=Lumsden|first4=Mary Ann|last5=Murad|first5=M. Hassan|last6=Pinkerton|first6=JoAnn V.|last7=Santen|first7=Richard J.|title=Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline|journal=The Journal of Clinical Endocrinology & Metabolism|volume=100|issue=11|year=2015|pages=3975–4011|issn=0021-972X|doi=10.1210/jc.2015-2236}}</ref>
 
<ref>https://www.nichd.nih.gov/health/topics/menopause/conditioninfo/treatments</ref>
 
*In women on [[hormone replacement therapy]], use the lowest possible dose for the shortest duration(3-5 years).
*In women on [[hormone replacement therapy]] with unscheduled [[bleeding]], evaluate for [[endometrial]] [[hyperplasia]] and [[endometrial]] [[cancer]].
*In women with [[primary ovarian insufficiency]] and [[surgical menopause]], [[hormonal replacement therapy]] to be given until anticipated age of [[menopause]].
*Counsel patients regarding continued symptoms after discontinuing [[hormone replacement therapy]].
*To maintain bone health recommended [[weight-bearing exercises]], [[calcium]] and [[vitamin D]] supplements.


==Don'ts==
==Don'ts==
<ref name="StuenkelDavis2015">{{cite journal|last1=Stuenkel|first1=Cynthia A.|last2=Davis|first2=Susan R.|last3=Gompel|first3=Anne|last4=Lumsden|first4=Mary Ann|last5=Murad|first5=M. Hassan|last6=Pinkerton|first6=JoAnn V.|last7=Santen|first7=Richard J.|title=Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline|journal=The Journal of Clinical Endocrinology & Metabolism|volume=100|issue=11|year=2015|pages=3975–4011|issn=0021-972X|doi=10.1210/jc.2015-2236}}</ref> <ref>https://www.nice.org.uk/guidance/ng23/chapter/Recommendations</ref>


* Do not use measurements of [[anti müllerian]] [[hormone]], [[inhibin B]], [[estradiol]], [[FSH]], [[LH]], [[testosterone]] in the diagnosis of menopause in women of age ≥45 years.
*Do not use measurements of [[anti müllerian]] [[hormone]], [[inhibin B]], [[estradiol]], [[FSH]], [[LH]], [[testosterone]] in the diagnosis of menopause in women of age ≥45 years. <ref name="StuenkelDavis2015">{{cite journal|last1=Stuenkel|first1=Cynthia A.|last2=Davis|first2=Susan R.|last3=Gompel|first3=Anne|last4=Lumsden|first4=Mary Ann|last5=Murad|first5=M. Hassan|last6=Pinkerton|first6=JoAnn V.|last7=Santen|first7=Richard J.|title=Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline|journal=The Journal of Clinical Endocrinology & Metabolism|volume=100|issue=11|year=2015|pages=3975–4011|issn=0021-972X|doi=10.1210/jc.2015-2236}}</ref> <ref>https://www.nice.org.uk/guidance/ng23/chapter/Recommendations</ref>
* Do not use [[FSH]] levels in diagnosing [[menopause]] in women <45 years of age who are on oral contraceptives.
*Do not use [[FSH]] levels in diagnosing [[menopause]] in women <45 years of age who are on oral contraceptives.
* Do not use [[hormonal]] replacement therapy in women with high risk for [[cardiovascular]] disease, [[venous thromboembolism]], [[breast cancer]].
*Do not use [[hormonal]] replacement therapy in women with high risk for [[cardiovascular]] disease, [[venous thromboembolism]], [[breast cancer]].
* Do not recommend use of [[complimentary medicine]] treatment options like [[black cohash]], [[omega-3 fatty acids]], [[red clover]], [[vitamin E]] due to lack of sufficient data proving its efficacy.
*Do not recommend use of [[complimentary medicine]] treatment options like [[black cohash]], [[omega-3 fatty acids]], [[red clover]], [[vitamin E]] due to lack of sufficient data proving its efficacy.
*Do not use [[ospemifene]] for [[vaginal]] dryness in women with history of [[breast cancer]].
*Do not use [[ospemifene]] for [[vaginal]] dryness in women with history of [[breast cancer]].


Line 76: Line 94:
{{Reflist|2}}
{{Reflist|2}}


[[Category:Help]]
[[Category:Projects]]
[[Category:Resident survival guide]]
[[Category:Resident survival guide]]
[[Category:Templates]]
[[Category:needs review]]
 
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 23:22, 30 July 2021

Menopause Resident Survival Guide Microchapters
Overview
Causes
Diagnosis
Treatment
Do's
Don'ts

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayeesha Kattubadi, M.B.B.S[2]

Synonyms and keywords: Perimenopause approach, Climacteric workup, Approach to menopause, Menopause workup, Menopause management

Overview

Menopause is a clinical state indicating the permanent cessation of ovarian function. Perimenopause refers to the period of transitioning before menopause characterised by irregular menstrual cycles. The diagnosis of menopause is made retrospectively based on the absence of menstrual cycles for 12 months. The average age of menopause is 51 years. Women can have symptoms of hot flashes, night sweats, sleep disturbance, mood changes, decreased libido, vaginal dryness, dyspareunia, etc. Women with intolerable symptoms can be treated with hormonal and non hormonal therapy. Conditions where menopause can occur early are primary ovarian insufficiency, bilateral oophorectomy, chemotherapy and radiation induced.

Causes

Common Causes

Commn causes of menopause include: [1] [2] [3] [4]

Diagnosis

Shown below is an algorithm summarizing the diagnosis of menopause. [5][6][7]

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Presence of Menopausal Symptoms
+ irregular/absent menstrual periods
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Age
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
≥45 years
 
 
 
 
 
 
 
 
 
 
40-45 years
 
 
 
 
 
 
 
 
 
≤40 years
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Uterus
 
 
 
 
 
 
 
 
 
 
Rule out other causes
like
pregnancy,
hyperthyroidism,
prolactinoma
 
 
 
 
 
 
 
 
 
Rule out
medical and surgical causes of
amenorrhea/oligomenorrhe
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Absent
 
 
 
Present
 
 
 
 
Normal
 
 
 
Abnormal
 
 
 
 
 
 
Measure
FSH and Estradiol
two samples
4-6 weeks apart
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Menopause diagnosed
based on
symptoms
 
Irregular periods+
menopausal symptoms
 
Amenorrhea>12 months
± menopausal symptoms
 
 
Amenorrhea > 12 months
 
 
 
Menopause ruled out
 
 
 
 
 
 
FSH elevated
Estradiol depressed
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Perimenopause
 
Menopause
 
 
Early menopause
 
 
 
 
 
 
 
 
 
 
 
 
Premature ovarian failure
 
 
 
 
 
 
 

Treatment

Shown below is an algorithm summarizing the treatment of menopause. [5] [8] [9]

 
 
 
 
 
 
 
 
 
 
 
 
 
Menopausal symptoms
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Genitourinary
syndrome of menopause
(vaginal dryness, itching,
dyspareunia, urinary incontinence)
 
 
 
 
 
 
 
 
 
Vasomotor symptoms
(hot flashes, night sweats)
 
 
 
 
 
 
 
 
Sleep problems
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Water based lubricants
Ospemifene
Vaginal oestrogen
 
 
 
 
 
 
 
 
 
Based on patient preference
 
 
 
 
 
 
 
 
Regular exercise
Sleep hygiene
Avoid alcohol and caffeine
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Life style
modification
 
 
 
 
 
 
 
Medical therapy
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-Avoid smoking, caffeine, alcohol
-Use of fan, cool bedroom, cool shower
-Relaxation exercises
 
 
 
Hormonal replacement
therapy
 
 
 
 
 
Non-hormonal
therapy
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Post hysterectomy status
 
 
 
 
 
When hormonal use
is contraindicated
(History of breast cancer,
Venous thromboembolism,
Undiagnosed vaginal bleeding, etc.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hysterectomised
 
 
 
Uterus in-situ
 
 
Paroxetine(SSRI)
Clonidine
Gabapentin
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Oestrogen alone
 
 
 
Oestrogen+Progesterone
 
 
 
 
 
 
 
 

Do's

[10]

Don'ts

References

  1. Rodriguez M, Shoupe D (2015). "Surgical Menopause". Endocrinol Metab Clin North Am. 44 (3): 531–42. doi:10.1016/j.ecl.2015.05.003. PMID 26316241.
  2. Secoșan C, Balint O, Pirtea L, Grigoraș D, Bălulescu L, Ilina R (2019). "Surgically Induced Menopause-A Practical Review of Literature". Medicina (Kaunas). 55 (8). doi:10.3390/medicina55080482. PMC 6722518 Check |pmc= value (help). PMID 31416275.
  3. Torrealday S, Kodaman P, Pal L (2017). "Premature Ovarian Insufficiency - an update on recent advances in understanding and management". F1000Res. 6: 2069. doi:10.12688/f1000research.11948.1. PMC 5710309. PMID 29225794.
  4. Liem GS, Mo FK, Pang E, Suen JJ, Tang NL, Lee KM; et al. (2015). "Chemotherapy-Related Amenorrhea and Menopause in Young Chinese Breast Cancer Patients: Analysis on Incidence, Risk Factors and Serum Hormone Profiles". PLoS One. 10 (10): e0140842. doi:10.1371/journal.pone.0140842. PMC 4613138. PMID 26485568.
  5. 5.0 5.1 5.2 5.3 Stuenkel, Cynthia A.; Davis, Susan R.; Gompel, Anne; Lumsden, Mary Ann; Murad, M. Hassan; Pinkerton, JoAnn V.; Santen, Richard J. (2015). "Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline". The Journal of Clinical Endocrinology & Metabolism. 100 (11): 3975–4011. doi:10.1210/jc.2015-2236. ISSN 0021-972X.
  6. https://www.nice.org.uk/guidance/ng23/chapter/Recommendations
  7. https://www.menopause.org.au/hp/gp-hp-resources/300-diagnosing-menopause
  8. "ACOG Releases Clinical Guidelines on Management of Menopausal Symptoms - Practice Guidelines - American Family Physician".
  9. "What are the treatments for other symptoms of menopause? | NICHD - Eunice Kennedy Shriver National Institute of Child Health and Human Development".
  10. https://www.nichd.nih.gov/health/topics/menopause/conditioninfo/treatments
  11. https://www.nice.org.uk/guidance/ng23/chapter/Recommendations